{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05692466",
            "orgStudyIdInfo": {
                "id": "DINOSAur"
            },
            "organization": {
                "fullName": "Glendale Adventist Medical Center d/b/a Adventist Health Glendale",
                "class": "OTHER"
            },
            "briefTitle": "Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting (\"DINOSAur\")",
            "officialTitle": "Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting (\"DINOSAur\")",
            "acronym": "DINOSAur",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "discovering-novel-cancer-treatment-options-using-a-comprehensive-ngs-based-molecular-testing-panel-in-the-community-setting-dinosaur"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-02-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-11-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-11-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-12-21",
            "studyFirstSubmitQcDate": "2023-01-10",
            "studyFirstPostDateStruct": {
                "date": "2023-01-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-03-01",
            "lastUpdatePostDateStruct": {
                "date": "2023-03-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Mihran Shirinian",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Glendale Adventist Medical Center d/b/a Adventist Health Glendale"
            },
            "leadSponsor": {
                "name": "Glendale Adventist Medical Center d/b/a Adventist Health Glendale",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Caris Life Sciences",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To prospectively identify cancer patients whose tumors express specific molecular markers targeted by therapeutic agents from a comprehensive molecular test, for the purpose of selecting the most clinically appropriate treatment in a pragmatic two arm trial."
        },
        "conditionsModule": {
            "conditions": [
                "Stage III Solid Tumors",
                "Stage IV Solid Tumors"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": true,
            "targetDuration": "2 Years",
            "designInfo": {
                "observationalModel": "CASE_CONTROL",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 572,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Active",
                    "description": "Newly diagnosed cancer patients.",
                    "interventionNames": [
                        "Diagnostic Test: Comprehensive molecular panel test",
                        "Other: EORTC QLQ-30"
                    ]
                },
                {
                    "label": "Control",
                    "description": "Historically diagnosed cancer patients."
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Comprehensive molecular panel test",
                    "description": "Lab test",
                    "armGroupLabels": [
                        "Active"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "EORTC QLQ-30",
                    "description": "Quality of life questionnaire",
                    "armGroupLabels": [
                        "Active"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "European Organization for Research and Treatment of Cancer quality of life Questionnaire-C30 (QLQ-C30)",
                    "description": "The EORTC Core Questionnaire (QLQ-C30) includes six clearly distinguishable functioning scales that have been thoroughly tested and validated on an international level and that are available in 110 different language versions.",
                    "timeFrame": "2 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Compare the proportion of patients enrolling in clinical trials",
                    "description": "To compare the proportion of enrolling in clinical trials between cancers patients who received the CMT versus cancer patients with no CMT.",
                    "timeFrame": "2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who have given informed consent in accordance with the methods and procedures of this study\n* Diagnosis of cancer (stage 3 and stage 4; solid tumors only) requiring medical care\n* Patients who have not received treatment related to his/her cancer\n* Patients who are willing to sign a release of medical records to the research team\n* Male and female patients \u226518 years of age\n* Patients under oncology care of a participating site\n* Sufficient clinical status for collection of biospecimen samples within usual care\n* Patients who have insurance coverage for CMT\n\nExclusion Criteria:\n\n* Patients considered minors in the jurisdiction where the protocol is conducted.\n* Patients who are prisoners and pregnant women.\n* Patients who cannot provide consent and did not sign a power of attorney.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Newly diagnosed cancer patients at the pathology level.",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Mihran H Shirinian, MD",
                    "role": "CONTACT",
                    "phone": "818-543-7574",
                    "email": "mshirin@aol.com"
                },
                {
                    "name": "Lily Villalobos, MHA",
                    "role": "CONTACT",
                    "phone": "818-409-8009",
                    "email": "villall3@ah.org"
                }
            ],
            "locations": [
                {
                    "facility": "Adventist Health Glendale",
                    "status": "RECRUITING",
                    "city": "Glendale",
                    "state": "California",
                    "zip": "91206",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mihran Shirinian, M.D.",
                            "role": "CONTACT",
                            "phone": "818-543-7574",
                            "email": "mshirin@aol.com"
                        },
                        {
                            "name": "Mihran Shirinian, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.14251,
                        "lon": -118.25508
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ]
        }
    },
    "hasResults": false
}